Health state utility in patients with osteoarthritis of the hip and total hip arthroplasty

Journal of Arthroplasty

Volumn 26, Issue SUPPL. 6, 2011, Pages 129-132.e2

  Bozic, Kevin J ^a,b   Chiu, Vanessa W ^a,b   Slover, James D ^c   Immerman, Igor ^c   Kahn, James G ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

Arthroplasty; Health state utility; Health related quality of life; Osteoarthritis

Indexed keywords

ADULT; ARTICLE; CHRONIC ARTHRITIS; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH STATUS; HIP OSTEOARTHRITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTHESIS INFECTION; QUALITY OF LIFE; RANK SUM TEST; RECURRENT DISLOCATION; REOPERATION; TOTAL HIP PROSTHESIS; TREATMENT FAILURE;

EID: 84868302758     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2011.03.033     Document Type: Article

References (21)

1. Ethgen O, Bruyere O, Richy F, et al. Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature. J Bone Joint Surg Am 2004;86-A:963.
2. Wiklund I, Romanus B. A comparison of quality of life before and after arthroplasty in patients who had arthrosis of the hip joint. J Bone Joint Surg Am 1991;73:765.
3. Bozic KJ, Ries MD. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am 2005;87:1746.
4. Robinson R. Cost-utility analysis. BMJ 1993;307:859.
5. Laupacis A, Bourne R, Rorabeck C, et al. The effect of elective total hip replacement on health-related quality of life. J Bone Joint Surg Am 1993;75:1619.
6. Katz JN, Phillips CB, Fossel AH, et al. Stability and responsiveness of utility measures. Med Care 1994;32:183.
7. Robinson AH, Palmer CR, Villar RN. Is revision as good as primary hip replacement? A comparison of quality of life. J Bone Joint Surg Br 1999;81:42.
8. Feeny D, Blanchard C, Mahon JL, et al. Comparing community-preference-based and direct standard gamble utility scores: evidence from elective total hip arthroplasty. Int J Technol Assess Health Care 2003;19:362.
9. Drummond M, Richardson W, O'Brien B, et al. Users's guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid? JAMA 1997;277:1552.
10. Drummond MF, Richardson WS, O'Brien BJ, et al. Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 1997;277:1552.
11. Tosteson AN, Hammond CS. Quality-of-life assessment in osteoporosis: health-status and preference-based measures. Pharmacoeconomics 2002;20:289.
12. Lawrence WF, Fleishman JA. Predicting EuroQoL EQ-5D preference scores from the SF-12 Health Survey in a nationally representative sample. Med Decis Making 2004; 24:160.
13. Soderman P, Malchau H, Herberts P. Outcome after total hip arthroplasty: part I. General health evaluation in relation to definition of failure in the Swedish National Total Hip Arthoplasty register. Acta Orthop Scand 2000; 71:354.
14. Rissanen P, Aro S, Sintonen H, et al. Costs and costeffectiveness in hip and knee replacements. A prospective study. Int J Technol Assess Health Care 1997;13:575.
15. Liang MH, Cullen KE, Larson MG, et al. Cost-effectiveness of total joint arthroplasty in osteoarthritis. Arthritis Rheum 1986;29:937.
16. Chang RW, Pellisier JM, Hazen GB. A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip. JAMA 1996;275:858.
17. James M, St Leger S, Rowsell KV. Prioritising elective care: a cost utility analysis of orthopaedics in the north west of England. J Epidemiol Community Health 1996; 50:182.
18. Rasanen P, Paavolainen P, Sintonen H, et al. Effectiveness of hip or knee replacement surgery in terms of qualityadjusted life years and costs. Acta Orthop 2007;78:108.
19. Tosteson AN, Stout NK, Fryback DG, et al. Cost-effectiveness of digital mammography breast cancer screening. Ann Intern Med 2008;148:1.
20. Churchill DN, Torrance GW, Taylor DW, et al. Measurement of quality of life in end-stage renal disease: the time trade-off approach. Clin Invest Med 1987;10:14.
21. Huang ES, Shook M, Jin L, et al. The impact of patient preferences on the cost-effectiveness of intensive glucose control in older patients with new-onset diabetes. Diabetes Care 2006;29:259.